Background. Human papillomavirus (HPV) types from the Betapapillomavirus and Gammapapillomavirus genera are common at cutaneous sites. The aim of this study was to analyze the prevalence of these HPV types in oral and nasal samples.
HPV-6, -11, -16, and -18) [2, 3] , as well as in cutaneous lesions (eg, HPV-2, -3, -7, and 27) [2] . HPV types of the genera Betapapillomavirus ( previously designated as epidermodysplasia verruciformis types) and Gammapapillomavirus are frequently detectable in cutaneous lesions [2, 4] , as well as on healthy skin [5] [6] [7] . The number of established HPV types and putative HPV types with described sequences of complete genomes among the genera Betapapillomavirus and Gammapapillomavirus is growing continuously. Today, the Betapapillomavirus and Gammapapillomavirus comprise about 45 and 60 HPV types, respectively [1, 6, [8] [9] [10] [11] . However, the extent of occurrence of Betapapillomavirus and Gammapapillomavirus HPV at anatomical sites other than the skin is less well understood, and extended knowledge about their tissue tropism might contribute to our understanding of the evolution of these HPV types. Recently, by the use of sensitive polymerase chain reaction (PCR) methods, these HPV types have been found to show tropism for the oral cavity of older males [9] , as well as for condylomas [12] .
The aim of the present study is to investigate the occurrence of Betapapillomavirus and Gammapapillomavirus HPV, in addition to Alphapapillomavirus HPV, in the nasal cavity by the use of general HPV detection methods.
MATERIALS AND METHODS

Study Population
The participants were medical personnel employed at departments of gynecology, dermatology, and venereology in Denmark. The participating departments of dermatology and venereology were located at Copenhagen University Hospital Gentofte, Copenhagen University Hospital Bispebjerg, Odense University Hospital, and Aarhus University Hospital. The participating departments of gynecology were located at Copenhagen University Hospital Hvidovre, Copenhagen University Hospital Herlev, Copenhagen University Hospital Hilleroed, Odense University Hospital, and Aarhus University Hospital. In addition, scientific staff from the medical faculty at Copenhagen University were invited to participate.
For participants to be included, they had to be at least 18 years of age and should not have treated patients with HPV-related diseases for 24 hours before sampling. All subjects were offered access to their personal results of Luminex analysis for detection of 39 genital HPV types; subsequent counseling, if needed; and retesting after 1 year, if they had a positive HPV result.
In each of the participating departments, a local project manager was appointed. The local project manager was trained in sampling and collected samples and questionnaires. Oral and nasal samples were collected from 312 participants, of whom 240 were women, and 72 were men. The mean age was 42 years (range, 25-68 years).
All participants provided written informed consent. The study was approved by the Scientific Ethical Committee of the Capital Region (H-D-2010-077).
The oral sample was obtained by gargling with 7 mL saline for approximately 30 seconds and then collecting the fluid with a funnel in a sterile 10-mL tube. The nasal sample was collected with a nylon-flocked tip moistened in saline that was placed approximately 1 cm inside the nostril and rotated 3 times against the nasal septum in each nostril. The tip was then stirred in 1.5 mL of saline in a cryo tube.
After centrifugation for 10 minutes at 3500 × g, the cell pellets were dissolved in the remaining 500 µL of saline, and DNA was extracted with the Total Nucleic Acid Isolation Kit (Roche) by the use of MagNA Pure LC (200 µL input and 100 µL output).
HPV Detection and Sample Adequacy Test
Three types of PCR analyses were performed. Real-time PCR was used to assess sample adequacy by testing 5 µL of the sample for the gene encoding human β-globin [12] . For modified general primer (MGP) PCR, 5 µL of extracted material was added to a total volume of 25 µL, and Luminex analysis was performed for identification of 39 genital HPV types simultaneously [13, 14] . Samples that were positive only for a universal probe were cloned and typed by sequencing (see below). For Forslund-Antonsson primers (FAP) 59/64 PCR, 5 µL was used in a total of 25 µL [15] , and HPV DNA was identified after gel electrophoresis of 5 µL. To improve the quality of direct sequencing and the efficiency of cloning, the remaining amplicon was purified by gel electrophoresis (QIAquick Gel Extraction Kit, Qiagen, Hilden, Germany) and diluted 1:100 for a second round of FAP59/64 PCR. Then the amplicon was purified by gel electrophoresis again (QIAquick Gel Extraction Kit) and sent for sequencing (Eurofins MWG Operon, Ebersberg, Germany).
A sequence from 1 strand of each FAP amplicon was used to search for HPV types through a BLAST search of the GenBank database (available at: http://www.ncbi.nlm.nih.gov/). For the direct sequencing, an isolate was classified as being a known HPV type if its sequence homology to the known HPV type was >90%.
In cases of low-quality sequence reads, the amplicon was cloned (TOPO TA Cloning Kit, Invitrogen), and 3 clones from each sample were sequenced. Among the cloned amplicons, a putative subtype was identified if sequence homology to a known HPV type was >90%-98%. A novel putative HPV type was identified if the similarity was <90%. Consensus sequences of novel subgenomic fragments of putative HPV types and putative subtypes were obtained from the cloned amplicons when at least 2 clones from each sample showed identical sequences. Sequences from 1 strand of high-quality reads without any ambiguities were used to describe novel subgenomic fragments of putative HPV types or subtypes when only a single clone was obtained.
Statistical Analysis
The nasal samples were evaluated for a possible correlation between the number of HPV types (range, 1-3 types obtained by cloning) and age. Correlation analyses were performed using a univariate nonparametric rank correlation test (the Spearman rank correlation test). Statistical significance was defined as a P value of < .05.
RESULTS
Eight nasal samples were excluded; six (2%) were excluded because of negative results in both β-globin real-time PCR and the HPV PCR, and 2 samples were missing. All oral samples were positive for β-globin, but 1 sample was missing. Therefore, 311 oral and 304 nasal samples were eligible for HPV analysis.
HPV DNA was detected in 6% of the oral samples and in 50% of the nasal samples. No differences in HPV prevalence were observed between men or women ( Table 1) . There was a similar HPV prevalence for the different age groups (Table 1) . Among those with HPV types in the nasal sample and for whom cloning was performed (54/152), there was a trend of an increased number of HPV types with age (P < .001; r = 0.59 [95% confidence interval, .37-.73]; Figure 1 ). The cloning approach also demonstrated that 67% of the HPV-positive nasal samples (36/54) had 2 or 3 HPV types detected simultaneously and that the mean number of HPV types was 1.6 for both sexes.
Alphapapillomavirus, Betapapillomavirus, and Gammapapillomavirus types were detected in 0.96%, 3.8%, and 1.6% of oral samples, respectively, and in 2.6%, 31%, and 16% of nasal samples, respectively ( Table 2 ). Stratification of Betapapillomavirus HPV revealed HPV types within species Beta-1, Beta-2, Beta-3, and Beta-5 in 17%, 9%, 7%, and 1% of the nasal samples, respectively.
HPV Types/Isolates
Among the oral and nasal samples, we identified 19 and 67 unique HPV types and putative types, respectively (Table 2 ). In total, 44 HPV types and 31 unique putative HPV types (subgenomic fragments) were identified (Table 3) . Five novel putative HPV types and 6 novel HPV subtypes were found (Table 4) .
For the nasal samples, the 4 most frequent types were HPV-76 (4.6%, including subtypes), HPV-124 (3.9%), HPV-24 (3.2%), and HPV-134 (2.9%; Table 3 ). Notably, the putative subtype FA167 of HPV76 (Beta-3) was detected in 7 nasal samples from 2 men (2.8%) and 5 women (2.1%).
In addition, 6 false, non-HPV amplicons (1.9%) were detected among the oral samples by the FAP PCR (single cases of Neisseria meningitidis, Lactobacillus kefiranofaciens, Enterobacter cloacae, Streptococcus mitis, Candida albicans, and human DNA). FAP PCR generated false amplicons of human DNA in 4 nasal samples (1.3%).
DISCUSSION
To our knowledge, this is the first demonstration that a wide spectrum of established cutaneous HPV types and putative HPV types of the Betapapillomavirus and Gammapapillomavirus genera are present in the nasal mucosa. In addition, in 7 nasal samples (2%), we detected a putative subtype (FA167) of HPV-76 that was originally isolated from a feline oral squamous cell carcinoma [18] .
To test for a broad range of HPV types, we used PCR methods capable of preferentially detecting Alphapapillomavirus HPV (MGP PCR) [13] and Betapapillomavirus and Gammapapillomavirus HPV (FAP PCR) [15] . The results of these methods were significantly different among our series of nasal samples. HPV DNA was detected in 3% (10/304) by the use of the MGP PCR, whereas the FAP PCR had a detection rate of 49% (149/304), which unexpectedly revealed that cutaneous Betapapillomavirus and Gammapapillomavirus HPV [2] also have a nasal tropism. Betapapillomavirus has frequently been detected in skin cancers among patients with epidermodysplasia verruciformis [17] but, together with Gammapapillomavirus, are also ubiquitous in healthy skin samples from healthy subjects [5] [6] [7] . However, the pathological impact, if any, of these HPV types in the nasal mucosa must be further investigated.
The HPV types in the nasal samples were probably not contaminants because we observed an increased number of HPV types by age; we detected 10 novel putative types/subtypes, including 7 isolates of the subtype FA167, that had not previously been reported from other human sources; and we found persistent HPV-16 infection in 1 subject, from whom the follow-up sample was collected after 20 months (data not shown). However, for another subject with HPV-30 in the first nasal sample, viral clearance was observed in follow-up samples collected after 24 months (data not shown). Future studies are needed to study the persistence of HPV types in the nasal mucosa.
We detected a low prevalence of high-risk HPV types (only HPV-16/18 were detected) in the nasal (1%) and oral (0.3%) samples. This is similar to the low prevalence of high-risk HPV types (0.63%) in mouthwash specimens from healthy Swedish controls [20, 21] . The overall occurrence of HPV types in the oral cavity was 6%, in agreement with findings from previous studies of healthy populations [20, 21] . However, among normal oral cavity samples, Rautava et al reported an increased HPV DNA prevalence of 17% in Finnish pregnant women [22] , Gichki et al found prevalences of 19% among females and 28% among males in Pakistan [23] , and Bottalico et al detected a prevalence of 37% among older men from the Ashkenazi Jewish community in the United States [9] . The reason for the large difference in HPV prevalence (4% vs 37%) between the men in our study and the men in the study by Bottalico et al might be due to the substantially greater mean age (44 years vs 68 years) in the latter study. It also possible that the large volume of mouthwash solution (44 mL) could have influenced the HPV prevalence reported by Bottalico et al. Interestingly, as in the current study, the latter study also used the FAP PCR. Bottalico et al found Betapapillomavirus to be the most common genus, with a prevalence of 27%, whereas Alphapapillomavirus and Gammapapillomavirus were detected in 9% and 3.7% of the oral cavity samples, respectively. Within our series, Betapapillomavirus types were also the most commonly detected HPVs but had substantially lower prevalence of only 3.8% in the oral cavity.
Notably, 7% of the nasal samples contained HPV types from Betapapillomavirus species Beta 3 (HPV-49, -75, and -76) [2] . In contrast, an approximately 10-fold lower prevalence (approximately 6%) of Betapapillomavirus species Beta 3 was found among skin samples by consensus HPV primer-mediated PCR [4, 24] . However, HPV-76 has been detected in 12.5% of skin swabs by the use of a type-specific arrayed primer extension PCR [25] . Interestingly, for the first time we isolated a putative subtype of HPV-76 (here labeled as FA167 to demonstrate isolation from a human source) from 7 nasal samples. The putative subtype was originally isolated from 1 of 20 feline oral squamous cell carcinomas (GenBank accession no. EF535004) [18] . Our findings support the suggestion by Munday et al that cats can be HPV infected by asymptomatic cat owners [26] . Although HPVs with sequence homology to cutaneous HPV-17 (Beta-2) and FAIMVS14 (Beta-2) have been detected in feline Bowenoid in situ carcinomas [26] , and HPV-9 (Beta-2) has been found in a feline cutaneous papilloma [27] , it remains to be determined if HPV types can cause lesions in cats.
The exact site for replication of HPV in the nasal mucosa remains unknown. However, the front portion of the nose contains hairs as the first air filter mechanism, and there are accumulating studies suggesting that hair follicles can serve as a reservoir for HPV types [28] [29] [30] . The eccrine ducts may also serve as reservoirs as described for the Gammapapillomavirus HPV-63 [31] . However, the detection rate of Betapapillomavirus was 31% in our nasal brush samples, which is similar to the value, 25%, detected in anogenital hairs [32] . Interestingly, Betapapillomavirus types appear to be substantially more prevalent in eyebrow hair samples, where prevalences of 67%, 89%, and 97% have been detected among healthy individuals [29, 33, 34] .
Among the cloned amplicons, we found a correlation between increased age and increased numbers of HPV types in the nasal sample. Increased occurrence of cutaneous HPV types by age has been demonstrated in an analysis of swab samples of skin [7] . One reason for the increase in HPV types with age might be the reduced activity of the immune system with aging [35] .
Among nasal samples, we identified a large spectrum of 67 unique HPV types and putative types, of which HPV-76 (β3), HPV-124 (β1), HPV-24 (β1), and HPV-134 (γ) were detected in 26% of the HPV-positive samples. Overall, the frequency of each HPV type and putative type detected in the series of nasal and oral samples was low (mean, 2 types; range, 1-14 types). This is in agreement with studies of various skin samples, which also demonstrated low frequencies for each HPV type, which, together, make up an array of preferentially Betapapillomavirus Abbreviations: Alpha, Alphapapillomavirus; Beta, Betapapillomavirus; Gamma, Gammapapillomavirus.
and Gammapapillomavirus types by different consensus HPV primer-mediated PCR [7, 15, 17, [36] [37] [38] [39] . Despite our study's strengths, some limitations deserve consideration. Detection of HPV types is dependent on sampling procedure and assay sensitivity and specificity. With regard to the sampling procedure, we cannot exclude the possibility that exfoliated cells from the perinasal region may have contaminated some of our nasal specimens. The study was performed on medical and scientific staff, and data from this group of persons may not be generalizable to other population groups. For example, medical staff may be more prone to HPV infection, because of their contact with patients.
In the present study, we used broad-range MGP PCR [13] for detection of at least 39 different HPV types from the genus Alphapapillomavirus by our Luminex system. Additional HPV types and isolates were identified by direct sequencing of MGP [16] . e GC isolates are described by Chouhy et al [17] .
f KC5 (GenBank accession no. JX444073) was detected by direct sequencing of a modified general primer PCR amplicon.
amplicons (eg, HPV-10, HPV-44, and isolate KC5) detected only by the general HPV probe included in the Luminex system. The Luminex MGP PCR is reliable for detection of HPV types and was recently used to identify 35 different HPV types from the genus Alphapapillomavirus among swab samples of condylomas [12] . For samples that were HPV positive by the single-round FAP PCR, which preferentially amplifies cutaneous Betapapillomavirus and Gammapapillomavirus, we used a nested FAP PCR approach to improve the quality of direct sequencing and the efficiency of cloning. By the use of cloning, 67% of the HPV-positive nasal samples harbored multiple HPV types, which demonstrates that the nested FAP PCR is capable of amplifying several HPV types simultaneously. In summary, we demonstrated that the nasal mucosa contains a large spectrum of HPV types from the Betapapillomavirus and Gammapapillomavirus genera. Our findings suggest an extended tropism for the nasal mucosa among the cutaneous Betapapillomavirus and Gammapapillomavirus types. The implications for the relatively high prevalence of Betapapillomavirus and Gammapapillomavirus HPV in the nasal mucosa remains unknown. 
Notes
